Date of Live Webinar
17 November 2021
10:00 AM CST – 11:00 AM CST
Because ISOQOL is an international society with members from all around the world and in numerous time zones, all webinars are recorded and made available to registrants within a few weeks of the live webinar.
Registration for the live webinar closes 16 November 2021 at 8:00 AM CST.
Healthcare resources are finite and priority decisions have to be made by regulatory bodies to align the need, clinical effectiveness, and cost-effectiveness of healthcare interventions and services. Cost-utility analysis (a type of cost-effectiveness analysis) using quality-adjusted life-years (QALYs) as the generic measure of health benefit are used to inform which treatments offer the “biggest bang for the buck” and to whom. Cost-utility analyses require data about the costs and the health benefit of the intervention. The health benefit can be measured using quantity (morbidity, remaining life years) or quality of life. Patient-reported outcome measures (PROMs) are one of the ways by which the quality of life can be measured. QALYs weight any improvements observed in quality of life (i.e., PROMs) and hence, measure outcomes over time. Including PROMs as the measure of health benefit in cost-effectiveness analyses translates to including patient’s voice in resource allocation decisions. In this webinar, we will begin by providing an overview of the history of measurement of health benefit in the form of PROMs in cost-effectiveness analysis. An overview of the key concepts and terminology typically used in the health economic evaluation literature will be provided. Following this, key methodological considerations for including PROMs when designing CEA study will be reviewed, alongside examples from published literature.
This webinar will enable participants to:
- develop an awareness and understanding of cost-effectiveness analysis in healthcare
- think through key issues around how PROs can be used to inform cost-effectiveness analysis
After the webinar, the attendee will be able to:
- Describe key concepts and terminology around CEA of health interventions
- Articulate key methodological considerations for including PROMs in CEA of health interventions
- Manraj Kaur, PT PhD, Research Fellow, Harvard Medical School
- Feng Xie, PhD, Professor, McMaster University
- Donna Rowen, PhD, Senior Research Fellow, University of Sheffield
Manraj Kaur, PT PhD, Research Fellow, Harvard Medical School
Health Preference Research SIG